Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer.

Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer. — المؤلف: Wong, Matthew K — Cancer chemotherapy and pharmacology 20100503

المؤلف
Wong, Matthew K
النشر
Cancer chemotherapy and pharmacology 20100503
الوصف
1023-8 p.
الموضوعات
Aged؛ Aged, 80 and over؛ Carcinoma, Non-Small-Cell Lung؛ Erlotinib Hydrochloride؛ Female؛ Gefitinib؛ Humans؛ Kaplan-Meier Estimate